The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search feed instagram google-plus avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content
| Childers, Schlueter & Smith

The Food and Drug Administration has requested that manufactures of leading anti-depressants add warnings to their labels to address recently discovered risks in newborns and migraine sufferers. The FDA’s concerns stem from a life threatening condition called serotonin syndrome, which has been linked to anti-depressants like Prozac and Zoloft. The FDA has also advised patients to consult with their doctors to determine if they should continue taking these medications given these recent findings. Those who have been taking anti-depressants and developed serotonin syndrome or other serious complications should consult with a personal injury attorney immediately to adequately protect their rights.

Comments are closed.